BOSTON SCIENTIFIC - Dusseldorf Stock Exchang (BSX DU) stock market data APIs
€85.9077
0(0%)
as of October 29, 2025
Try our APIs with
free plan!
BOSTON SCIENTIFIC - Dusseldorf Stock Exchang Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BSX.DU.
Prev. Close
85.9077
Open
85.9077
High
85.9077
Low
86.5976
52 wk Range
75.5-102
Market Cap
51 948 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BOSTON SCIENTIFIC - Dusseldorf Stock Exchang data using free add-ons & libraries
Get BOSTON SCIENTIFIC - Dusseldorf Stock Exchang Fundamental Data
BOSTON SCIENTIFIC - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get BOSTON SCIENTIFIC - Dusseldorf Stock Exchang Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-10-22
- EPS/Forecast: 0.71
Get BOSTON SCIENTIFIC - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BOSTON SCIENTIFIC - Dusseldorf Stock Exchang News
New
Canaccord Genuity Reiterates a Buy on Boston Scientific Corporation (BSX)
Boston Scientific Corporation (NYSE:BSX) is one of the Best Stocks to Buy for High Returns Heading into 2026. On October 23, William Plovanic from Canaccord Genuity reiterated a Buy rating on Bosto...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Many investors also have a go-to methodology that helps guide their buy and s...
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up
CVS Health Corporation CVS posted third-quarter 2025 adjusted earnings per share (EPS) of $1.60, up 46.8% year over year. The metric topped the Zacks Consensus Estimate by 17.65%. The adjusted EPS fig...
GE HealthCare Q3 Earnings and Revenues Beat Estimates, Net Margin Falls
GE HealthCare GEHC reported third-quarter 2025 adjusted earnings per share (EPS) of $1.07, which beat the Zacks Consensus Estimate of $1.05 by 1.9%. However, the bottom line declined 6.1% year over ye...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
